ASX/PAR (ASX/PAR)

Australian Securities Exchange: ASX/PAR · AUD

A$0.25

+0.00 (0.0%)· Recorded snapshot

Market cap	153.5M
Net income (ttm)	-56.3M
EPS (ttm)	-A$0.15
Shares out	626.4M
Volume	3,137,503
Beta	0.03

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -56.3M
EPS (ttm): -A$0.15
Market cap: 153.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-457

P25 n/aP50 n/aP75 n/a

ROIC-237.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/PAR indicators

Market & fundamental data

Available fields

159

Groups with data

Currency

AUD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-26
Enterprise value	AUD 145.5M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2014
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000PAR5
Last earnings date	2026-02-25
Last refreshed	2026-10-28
Market cap	AUD 153.5M
Next earnings date	2026-11-26
Price	AUD 0.25
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-09-18
Symbol	asx/PAR
Website	https://www.paradigmbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-62.14%
FCF / EV yield	-30.02%
FCF yield	-28.46%
Industry forward P/E	28.34x
P/B ratio	44.22x
Price / tangible book value	59.84x
Sector forward P/E	33.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-138.75%
ROA (5Y)	-77.43%
ROCE	-1,540.56%
ROE	-456.96%
ROE (5Y)	-172.31%
ROIC	-237.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth quarters	2
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	AUD 150,388
EBIT	AUD -61.2M
EBITDA	AUD -61M
EPS	AUD -0.15
FCF per share	AUD -0.07
Financing cash flow	AUD 43.7M
Free cash flow	AUD -43.7M
Free cash flow minus SBC	AUD -45.4M
Gross profit	AUD -12,128
Investing cash flow	AUD -552,317
Net borrowing	AUD 23M
Net cash flow	AUD -1.4M
Net income	AUD -56.3M
Operating cash flow minus SBC	AUD -45.4M
Operating income	AUD -61.2M
Stock-based compensation	AUD 1.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	AUD 0.01
Debt / equity	2.16
Interest coverage	-24.87
Long-term assets	AUD 1.4M
Long-term liabilities	AUD 501,290
Net cash (debt)	AUD 7.9M
Net cash / market cap	5.17%
Net cash growth	-52.8%
Net debt / equity	-2.29
Piotroski F-Score	1
Property, plant and equipment	AUD 499,103
Shareholders' equity	AUD 3.5M
Tangible book value	AUD 2.6M
Tangible book value per share	AUD 0.00
Total assets	AUD 30.6M
Total cash	AUD 15.4M
Total debt	AUD 7.5M
Total liabilities	AUD 27.1M
WACC	5.4%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	AUD 29.1M
Current liabilities	AUD 26.6M
Current ratio	1.1
Net working capital	AUD -5.7M
Quick ratio	1.07
Working capital	AUD 2.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-17.66%
Shareholder yield	-17.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-59.17%
10Y return CAGR	-8.03%
10Y total return	-56.69%
150-day SMA	AUD 0.20
1D price change	0%
1M price change	40%
1M total return	40%
1W price change	-14.04%
1W total return	-14.04%
1Y price change	-12.5%
1Y return CAGR	-12.51%
1Y total return	-12.5%
20-day SMA	AUD 0.24
200-day SMA	AUD 0.24
3M price change	36.11%
3M total return	36.11%
3Y price change	-63.97%
3Y return CAGR	-28.18%
3Y total return	-62.96%
50-day SMA	AUD 0.20
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.47
52-week high date	2025-10-24
52-week low	AUD 0.14
52-week low date	2026-06-10
5Y price change	-86.54%
5Y return CAGR	-32.57%
5Y total return	-86.06%
6M price change	-2%
6M total return	-2%
All-time high	AUD 4.50
All-time high date	2020-02-05
All-time low	AUD 0.14
All-time low date	2026-06-10
Average true range (ATR)	AUD 0.02
Average volume	3.7M
Beta (1Y)	0.88
Beta (2Y)	1.66
Beta (5Y)	0.03
Change from 52-week high	-47.87%
Change from 52-week low	81.48%
Change from all-time high	-94.56%
Change from all-time low	81.48%
Change from open	-3.92%
Day's gap	4.08%
Dollar volume	AUD 768,688
High price	AUD 0.27
Low price	AUD 0.25
Monthly RSI	42.57
Open price	AUD 0.26
Position in 52-week range	0%
Previous close	AUD 0.25
Price vs 150-day SMA	19.57%
Price vs 20-day SMA	2.17%
Price vs 200-day SMA	4.12%
Price vs 50-day SMA	22.87%
Relative volume	0.84
RSI	56.01
Sharpe ratio	0.15
Sharpe ratio (3Y)	-0.02
Sharpe ratio (5Y)	-0.15
Sortino ratio	0.3
Sortino ratio (3Y)	0.04
Sortino ratio (5Y)	-0.15
Volume	3.1M
Weekly RSI	56.94
YTD price change	-27.94%
YTD total return	-27.94%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	553.9M
Shares change (QoQ)	-21.17%
Shares change (YoY)	17.66%
Shares held by insiders	11.17%
Shares held by institutions	6.26%
Shares outstanding	626.4M

Deeper analysis on ASX/PAR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/PAR report

Is a complete ASX/PAR research report available?

No complete published report is available for asx/PAR (ASX/PAR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/PAR (ASX/PAR)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/PAR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/PAR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/PAR

Frequently asked questions